packageLebrikizumab

lebrikizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lebrikizumab is a monoclonal antibody used to treat atopic dermatitis. It is authorised in the European Union as a dermatological treatment for dermatitis.

Summary written by glm-5.3-flash from Wikidata Q3829321 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lebrikizumab
ATC codes:D11AH10
DrugBank:DB11914
Wikidata:Q3829321

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown